title: Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases.
authors.affiliation: aDepartment of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands bDepartment of Obstetrics and Gynecology, Ludwig-Maximillians-University of Munich, Munich, Germany cDepartment of Internal Medicine, Section on Infectiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Angela
authors.initials: A
authors.lastname: Colbers
authors.forename: Andrea
authors.initials: A
authors.lastname: Gingelmaier
authors.forename: Marchina
authors.initials: M
authors.lastname: van der Ende
authors.forename: Bart
authors.initials: B
authors.lastname: Rijnders
authors.forename: David
authors.initials: D
authors.lastname: Burger
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009570:Nitriles / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010949:Plasma / Q000737:chemistry; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000068696:Rilpivirine; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents; D009570:Nitriles; D011743:Pyrimidines; D000068696:Rilpivirine